Limbal Allograft, Amniotic Membrane Transplantation, and Intraoperative Mitomycin C for Recurrent Pterygium

To conduct a pilot study evaluating the efficacy and safety of limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C treatment for recurrent pterygium. Prospective, noncomparative, interventional case series. Twelve eyes of 11 patients with recurrent pterygium...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology Vol. 112; no. 7; pp. 1263 - 1267
Main Authors Miyai, Takashi, Hara, Ryuhei, Nejima, Ryohei, Miyata, Kazunori, Yonemura, Takaharu, Amano, Shiro
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2005
Elsevier BV
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To conduct a pilot study evaluating the efficacy and safety of limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C treatment for recurrent pterygium. Prospective, noncomparative, interventional case series. Twelve eyes of 11 patients with recurrent pterygium. The mean number of previous surgeries for pterygium was 1.9±1.4 (range, 1–6). All subjects received limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C. Pterygium recurrence and complications. The mean follow-up period was 21.6±5.6 months (range, 16–36 months). There was no pterygium recurrence in any of the eyes. Symblepharon reappeared in 3 eyes and diplopia recurred in 2 eyes. There were no other surgical complications and there was no graft rejection. Limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C may be a safe and effective procedure for recurrent pterygium.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0161-6420
1549-4713
1549-4713
DOI:10.1016/j.ophtha.2005.01.037